abstract |
Substituted benzo[d]isoxazol-3-yl amine compounds corresponding to formula I n n n n n n n n n n which exhibit an strong affinity to the KCNQ2/3 K + channel, and which are suitable for treating or inhibiting pain and/or disorders or disease states that are at least partly mediated by the KCNQ2/3 K + channel. |